Related Articles
Differential miRNA expression profiles in hepatocellular carcinoma cells and drug-resistant sublines
Silencing activating transcription factor 2 promotes the anticancer activity of sorafenib in hepatocellular carcinoma cells
Inhibition of cFLIP overcomes acquired resistance to sorafenib via reducing ER stress‑related autophagy in hepatocellular carcinoma
Combination of wogonin and sorafenib effectively kills human hepatocellular carcinoma cells through apoptosis potentiation and autophagy inhibition
Sorafenib inhibits cancer side population cells by targeting c‑Jun N‑terminal kinase signaling